Filing Details

Accession Number:
0001410939-22-000136
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-20 19:01:29
Reporting Period:
2022-12-18
Accepted Time:
2022-12-20 19:01:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Iveric Bio Inc. ISEE Pharmaceutical Preparations (2834) 208185347
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1703623 Francis David Carroll C/O Iveric Bio, Inc.
8 Sylvan Way
Parsippany NJ 07054
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-18 14,375 $0.00 68,995 No 4 M Direct
Common Stock Disposition 2022-12-19 5,671 $21.51 63,324 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-12-18 14,375 $0.00 14,375 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,750 No 4 M Direct
Footnotes
  1. Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
  2. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 18, 2022.
  3. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $21.19 to $21.95 on December 19, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
  4. On December 18, 2020, the Reporting Person was granted an award of 57,500 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.